MedX Health Corp Announces Operating Results For The Three Months Ended March 31, 2008.



    MISSISSAUGA, ON, June 2 /CNW/ - MedX Health Corp., a leader in the
development, manufacture and distribution of innovative phototherapy devices,
announces its results for the three months ended March 31, 2008.
    Revenue for the three months ended March 31, 2008 was $295,582 compared
to $312,712 for the three months ended March 31, 2007 a 5.5% decrease versus
the same period last year.
    MedX incurred a net loss of $688,604 in Q1 2008 compared to a net loss of
$545,368 for the same period in the prior year.

    
    -------------------------------------------------------------------------
    Canadian $                                        Q1  2008       Q1 2007
    -------------------------------------------------------------------------
    Revenue                                            295,582       312,712
    -------------------------------------------------------------------------
    Gross Margin %                                         69%           74%
    -------------------------------------------------------------------------
    Income (Loss) from continued operations           (687,144)     (544,462)
    -------------------------------------------------------------------------
    Income (Loss) from discontinued operations          (1,460)         (906)
    -------------------------------------------------------------------------
    Net Income (Loss) for period                      (688,604)     (545,368)
    -------------------------------------------------------------------------
    Weighted Average no. of shares outstanding -
     basic and diluted                              19,892,743    15,043,937
    -------------------------------------------------------------------------
    Loss per Common Share-basic and diluted             ($0.04)       ($0.00)
    -------------------------------------------------------------------------
    

    "Sales in the quarter were significantly higher than the previous
quarter, but slightly lower than last year. The US dollar continued to impact
comparative results with the prior period, however progress is being made to
increase volume in existing and the new dental markets. The completion of the
Company's IPO on January 31, 2008 is allowing the Company to embark on a more
aggressive marketing strategy and continue with its product development
strategy." said Steven Guillen, President of MedX Health.

    
    Significant achievements during the quarter were as follows:

    -  Completion of IPO for gross proceeds of $4,088,000.
    -  Continued development of new light therapy products and intellectual
       property associated thereto.
    -  Continued development of the Company's program for entry into the
       dental and wound care markets.
    

    About the Company - MedX, the phototherapy experts, are leaders in the
development, manufacture and distribution of innovative phototherapy medical
devices. MedX products offer effective treatment through a powerful and proven
modality - giving patients a rapid, drug free and non-invasive healing
solution. MedX products are used by practitioners in clinics, academic
facilities, and hospitals as well as by professional athletes and sports teams
to improve quality of life through accelerating healing and reducing pain.
MedX brand products are US FDA and Health Canada cleared and are produced in
an ISO 9001 and 13485 certified manufacturing and testing facility. For a
complete profile of MedX Health Corp. and its products visit
www.medXhealth.com

    %SEDAR: 00017466E




For further information:

For further information: Steve Guillen, President, MedX Health Corp.
Telephone: (905) 826-0766, Email: info@medxhealth.com

Organization Profile

MedX Health Corp.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890